"Impact of vitamin B12 on formation of the tetrachloroethene reductive dehalogenase in Desulfitobacterium hafniense strain Y51"
Despite the encouraging results of GLP-1/glucagon co-agonism in experimental models, different GLP-1 and glucagon co-agonists have shown various levels of efficacy and tolerability in people with obesity and/or T2D, in early phase clinical trials, which may be explained by the different ratio of GLP-1 to glucagon activity between the different molecules [65]
e0123423
Therefore, since the early 1990s, we have presented stable gastric pentadecapeptide BPC 157, and its pleiotropic beneficial effects, acting also via the per oral route [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40], as a late advantage of Robert and Szabos concept of cytoprotection [41,42,43,44,45,46,47,48,49]